Cite

1.American Thoracic Society. Adverse effects of silica exposure. Am J Respir Crit Care1997;155:755-761.10.1164/ajrccm.155.2.9032226Search in Google Scholar

2.Weill H, Jones RN, Parkes WR. Silicosis and related diseases. In: Parkes WR, editor. Occupational Lung Disorders, 3rd ed. Butterworths, London; 285–339.Search in Google Scholar

3.Leung CC, Yu IT, Chen W. Silicosis. Lancet 2012;379:2008-18.10.1016/S0140-6736(12)60235-9Search in Google Scholar

4.Centers for Disease Control and Prevention. Silicosis-related years of potential life lost before age 65 years-United States, 1968-2005. MMWR Morb Mortal Wkly Rep 2008;57:771-75.Search in Google Scholar

5. Rosenman KD, Reilly MJ, Kalinowski DJ. Silicosis in the 1990s. Chest 1997;111:779-86.10.1378/chest.111.3.779Search in Google Scholar

6.Centers for Disease Control and Prevention. Tuberculosis. Available: https://www.cdc.gov/tb/topic/basics/default.htm [Accessed on 20.10.2018].Search in Google Scholar

7.WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries. Available:https://extranet.who.int/sree/Reports?op=Replet&name=%2FWHO. [Accessed on 20.10.2018].Search in Google Scholar

8.Dheda K, Barry CE, Maartens G. Tuberculosis Lancet 2016;387:1211-26.Search in Google Scholar

9.Sonnenberg P, Murray J, Glynn JR Risk factors for pulmonary disease due to culture-positive M. tuberculosis or nontuberculous mycobacteria in South African gold miners. Eur Respir J 2000;2:291-96.10.1034/j.1399-3003.2000.15b12.x10706494Open DOISearch in Google Scholar

10.Liaquat A, Iram S, Hussain S. Concomitant presence of culture-proven active pulmonary tuberculosis in patients with chronic obstructive pulmonary disease - A hospital based study. Pak J Med Sci 2015;31:1344.Search in Google Scholar

11.Gossart S, Cambon C, Orfila C. Reactive oxygen intermediates as regulators of TNF-alpha production in rat lung inflammation induced by silica. J. Immunol 1996;156:1540-48.Search in Google Scholar

12.International Labour Office. Guidelines for the use of the ILO International Classification of Radiographs of Pneumoconioses, 2000 edition. Available:. International Labour Office. Guidelines for the use of the ILO International Classification of Radiographs of Pneumoconioses, 2000 edition (2002, Geneva ISBN: 92-2-110832-5) [Accessed on 20.10.2018].Search in Google Scholar

13.Leung C, Yu I, Chen W. Silicosis. Lancet 2012;379: 2008-18.10.1016/S0140-6736(12)60235-9Search in Google Scholar

14.Rees D, Murray J. Silica, silicosis and tuberculosis. Int J Tuberc Lung Dis 2007;11:474-84.Search in Google Scholar

15.Hnizdo E, Murray J. Risk of pulmonary tuberculosis relative to silicosis and exposure to silica dust in South African gold miners. Occup Environ Med 1998;55:496–502.10.1136/oem.55.7.49617576139816385Open DOISearch in Google Scholar

16.Knechel NA. Tuberculosis: Pathophysiology, Clinical Features, and Diagnosis. Crit Care Nurse 2009;29:34–43.10.4037/ccn200996819339446Search in Google Scholar

17.Bozzano F, Marras F, De Maria A. Immunology of tuberculosis. Mediterr J Hematol Infect Dis 2014;6:e2014027.10.4084/mjhid.2014.027401060724804000Search in Google Scholar

18 Amaral AF, Coton S, Kato B.Tuberculosis associates with both airflow obstruction and low lung function: BOLD results. Eur Respir J 2015;46:1104-12.10.1183/13993003.02325-2014459476226113680Search in Google Scholar

19.Ravimohan S, Kornfeld H, Weissman D.Tuberculosis and lung damage: from epidemiology to pathophysiology. Eur Respir Rev 2018; 27:170077.10.1183/16000617.0077-2017601955229491034Search in Google Scholar

20.Ross J, Ehrlich RI, Hnizdo E. Excess lung function decline in gold miners following pulmonary tuberculosis. Thorax 2010;65:1010–15.10.1136/thx.2009.12999920871124Open DOISearch in Google Scholar

21.Constantina C, Rașcu A, Trăilescu AM. Pulmonary silicotuberculosis in an electrician male - Case report and literature review. ARS Medica Tomitana 2012;3:140-5.10.2478/v10307-012-0027-5Search in Google Scholar

22.Arghir OC, Chiotan DI, Cioran NV. sub coordonarea prof.dr.Miron Alexandru Bogdan. Ghid metodologic de implementare a Programului Național de Prevenire, Supraveghere și Control al Tuberculozei. Ed. Alpha MDN, Buzău, 2015.Search in Google Scholar

23.Salgame P, Geadas C, Collins L. Latent tuberculosis infection. Revisiting and revising concepts. Tuberculosis 2015;95:373-84.10.1016/j.tube.2015.04.00326038289Search in Google Scholar

24.Ruhwald M, Dominguez J, Latorre I. A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis (Edinb) 2011;91:260–7.10.1016/j.tube.2011.01.00121459676Search in Google Scholar

25.Ruhwald M, Bodmer T, Maier C. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 2008;32:1607–15.10.1183/09031936.0005550818684849Search in Google Scholar

26.Yang Z, Li Q, Yao S. Down-Regulation of miR-19a as a biomarker for Early Detection of Silicosis. Anat Rec (Hoboken) 2016;299:1300-7.10.1002/ar.2338127312312Search in Google Scholar

27.Wu Q, Xu, T, Liu Y. miR-1224-5p Mediates Mitochondrial Damage to Affect Silica-Induced Pulmonary Fibrosis by Targeting BECN1. Int J Mol Sci 2017;18:2357.10.3390/ijms18112357571332629112159Search in Google Scholar

28.Miotto P, Mwangoka G, Valente IC. miRNA Signatures in Sera of Patients with Active Pulmonary Tuberculosis. PLoS ONE 2013;8:e80149.10.1371/journal.pone.0080149383698424278252Search in Google Scholar

eISSN:
2601-0828
Language:
English
Publication timeframe:
Volume Open
Journal Subjects:
Medicine, Clinical Medicine, other, Public Health, Pharmacology, Toxicology, Hygiene and Environmental Medicine